Tag: pharmaceuticals
-
Technique Developed to Extend Peptide Lifetimes
3 November 2015. A pharmacy lab at University of the Pacific developed a technique for extending the longevity of peptides, short amino acid chains found in many biologic drugs. The discovery from the lab of pharmacy professor Mamoun Alhamadsheh is described in this month’s issue of Nature Reviews Drug Discovery, and earlier in Nature Chemical…
-
Computer Model Devised to Predict Drug Side Effects
2 November 2015. A systems biology lab developed a prototype computer model that can test for potential side effects of drugs from an individual’s blood sample. The team led by bioengineering professor Bernhard Palsson at University of California in San Diego published its proof-of-concept results last week in the journal Cell Systems. Palsson and first…
-
Biotech, Accelerator to Partner on Glaucoma Treatment
30 October 2015. A new eye-drop treatment for the underlying causes of glaucoma is being developed in a collaboration between a biotechnology enterprise spun-off from Northwestern University and a company that acquires biomedical research assets. Financial aspects of the deal between Mannin Research Inc. in Toronto, Ontario, Canada and Q BioMed Inc. in New York…
-
Trial Underway Testing Breast Cancer Surgical Aid
29 October 2015. An early-stage clinical trial is recruiting participants to test a peptide that illuminates tumor cells to be removed in breast cancer surgery. The study is testing the experimental product made by Avelas Biosciences Inc., a biotechnology company in La Jolla, California. The clinical trial is enrolling individuals with primary, non-recurring breast cancer,…
-
Univ Lab, Spin-Off Developing Drug from Turmeric
28 October 2015. A university biochemistry lab and spin-off enterprise developing drugs from plants are collaborating on a process for extracting a key ingredient for an anti-inflammatory compound from the common spice turmeric. The project, bringing together the lab of biochemistry professor David Gang at Washington State University and Botanisol LLC in Scottsdale, Arizona, is…
-
Gene Editing Licensed for Inherited Disease Treatments
26 October 2015. A Boston biotechnology company is licensing gene-editing technologies from a nearby start-up to design treatments for cystic fibrosis and inherited blood disorders, including sickle cell disease. Vertex Pharmaceuticals, in Boston, received rights to techniques known as CRISPR-Cas9 in a deal that could bring CRISPR Therapeutics, founded in April 2014, as much as…
-
Two Current Drugs Shown Also to Promote Hair Growth
23 October 2015. Research originally designed to study hair loss from an autoimmune disorder, uncovered two drugs now on the market that in lab tests show they may also regrow hair. Findings of the study led by molecular dermatology professor Angela Christiano at Columbia University in New York appear in today’s issue of the journal…
-
First Results Released from Lung Fibrosis Registry
22 October 2015. The first results from a registry of individuals with idiopathic pulmonary fibrosis show most people in the group have limited lung function and show symptoms for about a year before the disease is diagnosed. These findings and other characteristics of people taking part in the Idiopathic Pulmonary Fibrosis – PRospective Outcomes (IPF-PRO)…
-
Trial Testing Aspirin to Prevent Cancer Recurrence
22 October 2015. A new late-stage clinical trial is underway in the U.K. testing the ability of a daily aspirin to prevent the recurrence of solid tumor cancers. The trial is financed by the advocacy group Cancer Research UK and National Institute for Health Research, a medical research funding agency. The study, led by oncologist…
-
Gates Grant Funding Whooping Cough Antibody Test
21 October 2015. A protein engineering lab at University of Texas in Austin is evaluating the potential of an engineered antibody to prevent pertussis, also known as whooping cough, among newborn infants. The study and lab are led by chemical engineering professor Jennifer Maynard, who is testing the antibody under a $400,000 grant from the…